DK149191C - Antiviralt virksom farmaceutisk olie-i-vand-formulering af 9-(2-hydroxyethoxymethyl)guanin(acyclovir) - Google Patents

Antiviralt virksom farmaceutisk olie-i-vand-formulering af 9-(2-hydroxyethoxymethyl)guanin(acyclovir)

Info

Publication number: DK149191C
Authority: DK; Denmark
Prior art keywords: hydroxyethoxymethyl; acyclovir; guanine; active pharmaceutical; water formulation
Prior art date: 1980-07-18

Application number

DK321681A

Other languages

Danish (da)

English (en)

Other versions

DK149191B (da

DK321681A (da

Inventor

Trevor Mervyn Jones

Alan Robert White

Original Assignee

Wellcome Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1980-07-18

Filing date

1981-07-17

Publication date

1986-09-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26276273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK149191(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1981-07-17 Application filed by Wellcome Found filed Critical Wellcome Found

1982-01-19 Publication of DK321681A publication Critical patent/DK321681A/da

1986-03-10 Publication of DK149191B publication Critical patent/DK149191B/da

1986-09-08 Application granted granted Critical

1986-09-08 Publication of DK149191C publication Critical patent/DK149191C/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dermatology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK321681A 1980-07-18 1981-07-17 Antiviralt virksom farmaceutisk olie-i-vand-formulering af 9-(2-hydroxyethoxymethyl)guanin(acyclovir) DK149191C (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB8023645		1980-07-18
GB8023645		1980-07-18
GB8033218		1980-10-15
GB8033218A GB2080106B (en)	1980-07-18	1980-10-15	Acyclovin preparations

Publications (3)

Publication Number	Publication Date
DK321681A DK321681A (da)	1982-01-19
DK149191B DK149191B (da)	1986-03-10
DK149191C true DK149191C (da)	1986-09-08

Family

ID=26276273

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK321681A DK149191C (da)	1980-07-18	1981-07-17	Antiviralt virksom farmaceutisk olie-i-vand-formulering af 9-(2-hydroxyethoxymethyl)guanin(acyclovir)

Country Status (30)

Country	Link
EP (1)	EP0044543B1 (it)
AR (1)	AR225680A1 (it)
AT (1)	AT381025B (it)
AU (1)	AU547391B2 (it)
BG (1)	BG60450B2 (it)
CA (1)	CA1172169A (it)
CS (1)	CS229674B2 (it)
CY (1)	CY1309A (it)
DD (1)	DD203464A5 (it)
DE (1)	DE3163982D1 (it)
DK (1)	DK149191C (it)
ES (1)	ES504046A0 (it)
FI (1)	FI76255C (it)
GB (1)	GB2080106B (it)
GR (1)	GR75104B (it)
HK (1)	HK95485A (it)
HU (1)	HU185936B (it)
IE (1)	IE51120B1 (it)
IL (1)	IL63351A (it)
IT (1)	IT1171399B (it)
MC (1)	MC1408A1 (it)
MY (1)	MY8600389A (it)
NO (1)	NO155038C (it)
NZ (1)	NZ197744A (it)
PH (1)	PH16308A (it)
PL (1)	PL135416B1 (it)
PT (1)	PT73391B (it)
RO (1)	RO82678A (it)
SG (1)	SG72085G (it)
ZW (1)	ZW17181A1 (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0095813A3 (en) *	1982-06-01	1985-05-08	THE PROCTER & GAMBLE COMPANY	Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine
US4557934A (en)	1983-06-21	1985-12-10	The Procter & Gamble Company	Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
GB8602346D0 (en) *	1986-01-30	1986-03-05	Wellcome Found	Antiviral combinations
GB8917959D0 (en) *	1989-08-05	1989-09-20	Beecham Group Plc	Pharmaceutical formulation
US6469015B1 (en)	1990-01-26	2002-10-22	Novartis International Pharmaceutical Ltd	Pharmaceutical formulation
GB9001886D0 (en) *	1990-01-26	1990-03-28	Beecham Group Plc	Pharmaceutical formulation
EP0773091A3 (en) *	1992-03-20	1998-04-01	Unichema Chemie B.V.	Release composition
DK169121B1 (da) *	1992-09-09	1994-08-22	Gea Farmaceutisk Fabrik As	Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
DE4416674C2 (de) *	1994-05-11	1997-01-30	Rentschler Arzneimittel	Topische Zubereitung enthaltend Aciclovir
DE19517147C2 (de) *	1995-05-10	1999-07-01	Hexal Pharmaforschung Gmbh	Aciclovir-Zubereitung
WO1997034607A1 (en) *	1996-03-20	1997-09-25	Glaxo Group Limited	Topical formulations of aciclovir
GB9611167D0 (en) *	1996-05-29	1996-07-31	Glaxo Group Ltd	Medicaments
GB9718568D0 (en)	1997-09-03	1997-11-05	Chauvin Pharmaceuticals Limite	Compositions
GB9718791D0 (en) *	1997-09-05	1997-11-12	Glaxo Group Ltd	Medicaments
ITMI981528A1 (it) *	1998-07-03	2000-01-03	Recordati Ind Chimica E Farma	Formulazioni topiche di aciclovir
US7223387B2 (en)	1998-11-18	2007-05-29	Medivir Ab	Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
GB9828620D0 (en) *	1998-12-23	1999-02-17	Glaxo Group Ltd	Medicaments
FR2837102B1 (fr) *	2002-03-18	2004-10-08	Palbian Snc	Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
ES2308170T3 (es) *	2004-04-05	2008-12-01	Laboratorios Liomont, S.A. De C.V.	Nueva composicion farmaceutica antiviral.
EP2005824A1 (de) †	2007-06-21	2008-12-24	Bayer CropScience AG	Wirkstoffsuspensionen in Glycerin
EP3337512A1 (en)	2015-08-17	2018-06-27	Sanovel Ilac Sanayi ve Ticaret A.S.	A topical antiviral composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3892857A (en) *	1972-11-24	1975-07-01	Squibb & Sons Inc	Steroid formulation
ZA738657B (en) *	1973-01-05	1974-10-30	Hoffmann La Roche	Emulsions
GB1478009A (en) *	1973-04-02	1977-06-29	Glaxo Lab Ltd	Pharmaceutical compositions
US4199574A (en) *	1974-09-02	1980-04-22	Burroughs Wellcome Co.	Methods and compositions for treating viral infections and guanine acyclic nucleosides
GB1543907A (en) *	1975-02-19	1979-04-11	Dermal Labor Ltd	Steroid compositions
US3934013A (en) *	1975-02-21	1976-01-20	Syntex (U.S.A.) Inc.	Pharmaceutical composition
US4049802A (en) *	1975-03-19	1977-09-20	Research Corporation	Zinc sulfadiazine and its use in the treatment of burns
GB1554720A (en) *	1975-07-10	1979-10-24	Nyegaard & Co As	Pyridthione derivatives
US4144332A (en) *	1976-01-05	1979-03-13	The Regents Of The University Of Michigan	Process for alleviating proliferative skin diseases
DE2847975A1 (de) *	1978-11-04	1980-05-14	Merck Patent Gmbh	Verfahren zur bindung von freiem formaldehyd in pharmazeutischen und kosmetischen zubereitungen

1980
- 1980-10-15 GB GB8033218A patent/GB2080106B/en not_active Expired
1981
- 1981-07-17 BG BG052984A patent/BG60450B2/bg unknown
- 1981-07-17 PH PH25929A patent/PH16308A/en unknown
- 1981-07-17 DD DD81231891A patent/DD203464A5/de unknown
- 1981-07-17 AU AU73073/81A patent/AU547391B2/en not_active Expired
- 1981-07-17 CY CY1309A patent/CY1309A/xx unknown
- 1981-07-17 HU HU812097A patent/HU185936B/hu not_active IP Right Cessation
- 1981-07-17 CA CA000381977A patent/CA1172169A/en not_active Expired
- 1981-07-17 FI FI812257A patent/FI76255C/fi not_active IP Right Cessation
- 1981-07-17 GR GR65549A patent/GR75104B/el unknown
- 1981-07-17 EP EP81105635A patent/EP0044543B1/en not_active Expired
- 1981-07-17 ZW ZW171/81A patent/ZW17181A1/xx unknown
- 1981-07-17 PT PT73391A patent/PT73391B/pt unknown
- 1981-07-17 AT AT0318081A patent/AT381025B/de not_active IP Right Cessation
- 1981-07-17 NZ NZ197744A patent/NZ197744A/xx unknown
- 1981-07-17 IE IE1617/81A patent/IE51120B1/en not_active IP Right Cessation
- 1981-07-17 CS CS815507A patent/CS229674B2/cs unknown
- 1981-07-17 NO NO812464A patent/NO155038C/no unknown
- 1981-07-17 DE DE8181105635T patent/DE3163982D1/de not_active Expired
- 1981-07-17 IL IL63351A patent/IL63351A/xx not_active IP Right Cessation
- 1981-07-17 ES ES504046A patent/ES504046A0/es active Granted
- 1981-07-17 PL PL1981232259A patent/PL135416B1/pl unknown
- 1981-07-17 DK DK321681A patent/DK149191C/da active
- 1981-07-17 IT IT48925/81A patent/IT1171399B/it active Protection Beyond IP Right Term
- 1981-07-17 MC MC811529A patent/MC1408A1/xx unknown
- 1981-07-17 AR AR286131A patent/AR225680A1/es active
1982
- 1982-07-17 RO RO82104911A patent/RO82678A/ro unknown
1985
- 1985-10-05 SG SG720/85A patent/SG72085G/en unknown
- 1985-11-28 HK HK954/85A patent/HK95485A/xx not_active IP Right Cessation
1986
- 1986-12-30 MY MY389/86A patent/MY8600389A/xx unknown

Also Published As

Publication number	Publication date
IL63351A0 (en)	1981-10-30
GB2080106A (en)	1982-02-03
PL135416B1 (en)	1985-10-31
HU185936B (en)	1985-04-28
AU547391B2 (en)	1985-10-17
FI812257L (fi)	1982-01-19
NO155038C (no)	1987-02-04
FI76255B (fi)	1988-06-30
EP0044543A1 (en)	1982-01-27
DK149191B (da)	1986-03-10
FI76255C (fi)	1990-03-14
PT73391B (en)	1983-06-15
BG60450B2 (bg)	1995-04-28
IE811617L (en)	1982-01-18
ATA318081A (de)	1986-01-15
GR75104B (it)	1984-07-13
DE3163982D1 (en)	1984-07-12
IT8148925A0 (it)	1981-07-17
ES8305363A1 (es)	1983-04-01
ZW17181A1 (en)	1983-02-23
MY8600389A (en)	1986-12-31
SG72085G (en)	1986-05-02
NZ197744A (en)	1983-05-10
IE51120B1 (en)	1986-10-01
AU7307381A (en)	1982-01-21
CA1172169A (en)	1984-08-07
PH16308A (en)	1983-09-05
ES504046A0 (es)	1983-04-01
NO812464L (no)	1982-01-19
MC1408A1 (fr)	1982-07-16
DD203464A5 (de)	1983-10-26
AT381025B (de)	1986-08-11
PL232259A1 (en)	1983-07-04
GB2080106B (en)	1984-03-07
AR225680A1 (es)	1982-04-15
EP0044543B1 (en)	1984-06-06
CS229674B2 (en)	1984-06-18
DK321681A (da)	1982-01-19
PT73391A (en)	1981-08-01
IT1171399B (it)	1987-06-10
CY1309A (en)	1985-12-06
HK95485A (en)	1985-12-06
NO155038B (no)	1986-10-27
RO82678A (ro)	1984-05-23
IL63351A (en)	1983-10-31

Publication	Publication Date	Title
DK149191C (da)	1986-09-08	Antiviralt virksom farmaceutisk olie-i-vand-formulering af 9-(2-hydroxyethoxymethyl)guanin(acyclovir)
NO830316L (no)	1983-08-02	Fremgangsmaate for fremstilling av antivirale purinderivater
US4355032B2 (en)	1990-10-30	9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
DE3485225D1 (de)	1991-12-05	Antivirale guanin-derivate.
YU40080B (en)	1985-06-30	Pocess for obtaining 9-(2-hydroxyethoxymethyl)guanine derivatives of purine
LV5264A3 (lv)	1993-10-10	Panemiens guanina atvasinajumu vai to farmaceitiski pielietojamu skabju-aditivo saju iegusanai
FI840890A0 (fi)	1984-03-06	Foerbaettringar i eller angaoende difluoro innehaollande antivirala aemnen
DE3671227D1 (de)	1990-06-21	9-substituierte guaninmonohydrate.
AU1527983A (en)	1983-12-08	Topical pharmaceutical compositions containing 9- (2-hydroxyethoxymethyl) guanine
FI782527A (fi)	1979-02-20	Pyrido(1,2-a)pyrimidin-derivat foerfarande foer deras framstaellning och desamma innehaollande farmaceutiska blandningar
DK418489D0 (da)	1989-08-24	Anvendelse af purinderivater til fremstilling af antivirale farmaceutika
DK71187A (da)	1987-08-15	Purinderivater
ES456407A1 (es)	1978-07-01	Un metodo de preparacion de una purina sustituida.
SE432764B (sv)	1984-04-16	Forfarande for framstellning av 2-amino-9-(2-hydroxietoximetyl) adenin och 9-(2-hydroxietoximetyl) guanin
IT8224311A0 (it)	1982-11-18	Derivati del pirimidin-4-one adattivita' erbicida.
NL7802111A (nl)	1978-08-28	9-(2-hydroxyethoxymethyl) guaninemonofosfaat en zijn zouten.
DK448983A (da)	1984-03-31	1-monophosphatestere, 1,3-bisphosphatestere og cykliske phosphatestere af 9-(1,3-dihydroxy-2-propoxymethyl)guanin som antivirale midler
IT1222142B (it)	1990-09-05	Composizioni farmaceutiche antivirali
ZA833947B (en)	1984-02-29	Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl)guanine
NO930160D0 (no)	1993-01-18	Antivirale fosfono-alken-derivater av puriner
PH20807A (en)	1987-04-21	2-amino-9-(2-hydroxyethoxymethyl)-9h-purine and salts thereof,their pharmaceutical formulations and their use
LV5704A3 (lv)	1995-02-20	9-(2-Oksietoksimetil)guanina iegusanas panemiens
ES539795A0 (es)	1985-11-16	Procedimiento para la obtencion de 9-(2-hidroxietoximetil) guanina
IT8221520A0 (it)	1982-05-27	Procedimento per la preparazione della 9-(2-idrossietossiemtil)guanina
ATE16566T1 (de)	1985-12-15	Arzneimittelform von theophyllin mit verlaengerter wirkung.